August 5, 2026 AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and Aging
August 5, 2026 Infor Appoints Yuka Kanemitsu as President and Representative Director of Infor Japan to Accelerate Industry Cloud Growth and AI-Driven Business Transformation
August 5, 2026 Funeral.com Expands Cremation Urns, Cremation Jewelry and Pet Urns With MacKenzie Urn+Vault
